Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Cov2, Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04583995
What this trial is testing

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Novavax 15,185
Not applicableUnknownNCT05408299
What this trial is testing

Comparative Study of Patterns of Immune Response to COVID 19 Vaccination

Who this might be right for
Immune Response to Covid 19 Vaccination
National Research Centre, Egypt 100
Not applicableStudy completedNCT05104385
What this trial is testing

Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences

Who this might be right for
COVID-19 PandemicSARS-CoV2 InfectionImmunization; Infection+1 more
Hacettepe University 1,223
Large-scale testing (Phase 3)Ended earlyNCT05220397
What this trial is testing

Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Recipient
Mark Stegall 468
Not applicableUnknownNCT05398718
What this trial is testing

Study on Sotrovimab and Its Impact on the Immune Response to COVID-19 Infection in Real-life in the UAE and Bahrain

Who this might be right for
COVID-19
Abu Dhabi Health Services Company 20,000
Not applicableStudy completedNCT05620251
What this trial is testing

Response to BNT162b2 Vaccine in Adolescents With Type 1 Diabetes

Who this might be right for
type1diabetes
Istanbul Medeniyet University 121
Not applicableStudy completedNCT05060354
What this trial is testing

COVID-19 Vaccine Response in Treated MS Patients

Who this might be right for
Multiple SclerosisHealthy
Brigham and Women's Hospital 159
Not applicableStudy completedNCT04918888
What this trial is testing

COVID-19 Vaccination in Oncologic Patients

Who this might be right for
Covid19Oncologic Disorders
Krankenhaus Barmherzige Schwestern Linz 1,150
Not applicableStudy completedNCT05328479
What this trial is testing

Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in Thailand

Who this might be right for
COVID-19
Mahidol University 5,181
Not applicableUnknownNCT04381845
What this trial is testing

Immunity and Infections in the Psychiatric Population

Who this might be right for
COVIDPsychiatric Disorders
Assistance Publique - Hôpitaux de Paris 200
Not applicableStudy completedNCT05089565
What this trial is testing

Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis

Who this might be right for
SarcoidosisSARS-CoV2 InfectionVaccine Response Impaired
Northwestern University 101
Not applicableStudy completedNCT05096962
What this trial is testing

COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

Who this might be right for
COVID-19SARS-CoV-2 Infection
Institute of Health Information and Statistics of the Czech Republic 7,268
Testing effectiveness (Phase 2)Study completedNCT04566276
What this trial is testing

ChulaCov19 Vaccine in Healthy Adults

Who this might be right for
COVID-19 VaccineSafety Issues
Chulalongkorn University 192
Post-approval studies (Phase 4)Ended earlyNCT04878211
What this trial is testing

Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals 24
Not applicableUnknownNCT05484700
What this trial is testing

Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms

Who this might be right for
Long COVID-19
Mahidol University 305
Not applicableUnknownNCT04465981
What this trial is testing

Investigation of Antibody and Immune Responses to SARS-CoV-2 Proteins in COVID-19 Patients

Who this might be right for
COVID-19SARS-CoV-2 Infection
INanoBio Inc. 80
Large-scale testing (Phase 3)WithdrawnNCT04848467
What this trial is testing

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19)
Bayer
Not applicableStudy completedNCT05228912
What this trial is testing

Immunization of 7 Different Vaccines Against SARS-COV-2 Across 4 Countries.

Who this might be right for
Vaccine Adverse ReactionCOVID-19Vaccine Reaction
Hospital Clinica Nova 1,870
Not applicableStudy completedNCT04588363
What this trial is testing

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 244
Not applicableStudy completedNCT04385108
What this trial is testing

Predictive Immune Biomarkers for COVID-19 Pathogenesis

Who this might be right for
COVID-19
University Hospital, Toulouse 565
Next Page